256 related articles for article (PubMed ID: 15825018)
1. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
Rajendram R; Alp NJ; Mitchell AR; Bowler IC; Forfar JC
Clin Infect Dis; 2005 May; 40(9):e72-4. PubMed ID: 15825018
[TBL] [Abstract][Full Text] [Related]
2. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
Lye DC; Hughes A; O'Brien D; Athan E
Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
[TBL] [Abstract][Full Text] [Related]
3. Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment.
Jiménez-Expósito MJ; Torres G; Baraldés A; Benito N; Marco F; Paré JC; Moreno A; Claramonte X; Mestres CA; Almela M; García de la María C; Pérez N; Schell WA; Corey GR; Perfect J; Jiménez de Anta MT; Gatell JM; Miró JM
Clin Infect Dis; 2004 Oct; 39(7):e70-3. PubMed ID: 15472836
[TBL] [Abstract][Full Text] [Related]
4. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Prabhu RM; Orenstein R
Clin Infect Dis; 2004 Oct; 39(8):1253-4. PubMed ID: 15486856
[No Abstract] [Full Text] [Related]
5. Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient--case report and review of literature.
Bacak V; Biocina B; Starcevic B; Gertler S; Begovac J
J Infect; 2006 Jul; 53(1):e11-4. PubMed ID: 16274746
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin: a new therapeutic option for fungal endocarditis.
Nevado J; De Alarcón A; Hernández A
Clin Microbiol Infect; 2005 Mar; 11(3):248. PubMed ID: 15715728
[No Abstract] [Full Text] [Related]
8. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
López-Ciudad V; Castro-Orjales MJ; León C; Sanz-Rodríguez C; de la Torre-Fernández MJ; Pérez de Juan-Romero MA; Collell-Llach MD; Díaz-López MD
BMC Infect Dis; 2006 Apr; 6():73. PubMed ID: 16608509
[TBL] [Abstract][Full Text] [Related]
9. Candida endocarditis: role of new antifungal agents.
Talarmin JP; Boutoille D; Tattevin P; Abgueguen P; Ansart S; Roblot F; Raffi F
Mycoses; 2009 Jan; 52(1):60-6. PubMed ID: 18498304
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin: a potential cause of reversible severe thrombocytopenia.
Lynch J; Wong-Beringer A
Pharmacotherapy; 2004 Oct; 24(10):1408-11. PubMed ID: 15628837
[TBL] [Abstract][Full Text] [Related]
11. [Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
Piñar D; Reus S; Pérez P; Quiles JA
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):66-7. PubMed ID: 19419799
[No Abstract] [Full Text] [Related]
12. Endocarditis caused by Candida dubliniensis.
Garcia J; Soch K; Matthew E; Surani S; Horseman MA
Am J Med Sci; 2013 Sep; 346(3):237-9. PubMed ID: 23974269
[TBL] [Abstract][Full Text] [Related]
13. Candida infective endocarditis: report of 15 cases from a prospective multicenter study.
Falcone M; Barzaghi N; Carosi G; Grossi P; Minoli L; Ravasio V; Rizzi M; Suter F; Utili R; Viscoli C; Venditti M;
Medicine (Baltimore); 2009 May; 88(3):160-168. PubMed ID: 19440119
[TBL] [Abstract][Full Text] [Related]
14. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis.
Muehrcke DD; Lytle BW; Cosgrove DM
Ann Thorac Surg; 1995 Sep; 60(3):538-43. PubMed ID: 7677477
[TBL] [Abstract][Full Text] [Related]
15. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.
Moudgal V; Little T; Boikov D; Vazquez JA
Antimicrob Agents Chemother; 2005 Feb; 49(2):767-9. PubMed ID: 15673762
[TBL] [Abstract][Full Text] [Related]
16. Candida glabrata endophthalmitis treated successfully with caspofungin.
Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
[TBL] [Abstract][Full Text] [Related]
17. A rare case of fungal endocarditis caused by Candida glabrata after completion of antibiotic therapy for Streptococcus endocarditis.
Tsugu T; Murata M; Iwanaga S; Kitamura Y; Inoue S; Fukuda K
J Med Ultrason (2001); 2015 Apr; 42(2):243-6. PubMed ID: 26576579
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin as treatment for Candida glabrata hip infection.
Lejko-Zupanc T; Mozina E; Vrevc F
Int J Antimicrob Agents; 2005 Mar; 25(3):273-4. PubMed ID: 15737527
[No Abstract] [Full Text] [Related]
19. Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans.
Victorio GB; Bourdon LMB; Benavides LG; Huerta-Olvera SG; Plascencia A; Villanueva J; Martinez-Lopez E; Hernández-Cañaveral II
Mem Inst Oswaldo Cruz; 2017 May; 112(5):370-375. PubMed ID: 28443984
[TBL] [Abstract][Full Text] [Related]
20. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
